SE8306384L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8306384L
SE8306384L SE8306384A SE8306384A SE8306384L SE 8306384 L SE8306384 L SE 8306384L SE 8306384 A SE8306384 A SE 8306384A SE 8306384 A SE8306384 A SE 8306384A SE 8306384 L SE8306384 L SE 8306384L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
pepsin
human
composition
gout
Prior art date
Application number
SE8306384A
Other languages
Unknown language ( )
English (en)
Other versions
SE8306384D0 (sv
SE460825B (sv
Inventor
H Ohnishi
H Kosuzume
Y Suzuki
E Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8306384D0 publication Critical patent/SE8306384D0/sv
Publication of SE8306384L publication Critical patent/SE8306384L/sv
Publication of SE460825B publication Critical patent/SE460825B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8306384A 1982-11-20 1983-11-18 Komposition foer behandling av infektionssjukdomar, gikt och arterioscleros, innehaallande humant pepsin och/eller humant leukocyt-pepsinliknande enzym SE460825B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57203990A JPS5995221A (ja) 1982-11-20 1982-11-20 食細胞機能調節作用を有する医薬組成物

Publications (3)

Publication Number Publication Date
SE8306384D0 SE8306384D0 (sv) 1983-11-18
SE8306384L true SE8306384L (sv) 1984-05-21
SE460825B SE460825B (sv) 1989-11-27

Family

ID=16482949

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8306384A SE460825B (sv) 1982-11-20 1983-11-18 Komposition foer behandling av infektionssjukdomar, gikt och arterioscleros, innehaallande humant pepsin och/eller humant leukocyt-pepsinliknande enzym

Country Status (11)

Country Link
US (1) US4534966A (sv)
JP (1) JPS5995221A (sv)
AU (1) AU552756B2 (sv)
CA (1) CA1204054A (sv)
CH (1) CH657050A5 (sv)
DE (1) DE3341760A1 (sv)
FR (1) FR2536281B1 (sv)
GB (1) GB2132481B (sv)
IT (1) IT1174799B (sv)
NL (1) NL8303980A (sv)
SE (1) SE460825B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309072B2 (en) * 2004-11-12 2012-11-13 The Zhabilov Trust Irreversibly-inactivated pepsinogen fragments for modulating immune function
US8067531B2 (en) 2004-11-12 2011-11-29 The Zhabilov Trust Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells
WO2007041285A2 (en) * 2005-09-29 2007-04-12 Viral Genetics, Inc. Complexes of inactivated pepsin fraction and heat shock protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR59346E (fr) * 1949-06-09 1954-05-24 Valise roulante
US2930736A (en) * 1957-01-07 1960-03-29 Nat Drug Co Stabilized trypsin compositions containing partially hydrolyzed gelatin and method of making
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
CA1181005A (en) * 1981-02-10 1985-01-15 Haruo Ohnishi Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors
WO1983002724A1 (en) * 1982-02-09 1983-08-18 Ohnishi, Haruo Agent for treating allergic disease, immunity complex disease, and tumor
WO1983004260A1 (en) * 1982-05-31 1983-12-08 Mochida Pharmaceutical Co., Ltd. Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor

Also Published As

Publication number Publication date
IT1174799B (it) 1987-07-01
GB2132481B (en) 1987-02-11
SE8306384D0 (sv) 1983-11-18
NL8303980A (nl) 1984-06-18
FR2536281A1 (fr) 1984-05-25
GB8330810D0 (en) 1983-12-29
AU2155483A (en) 1984-05-24
FR2536281B1 (fr) 1989-05-12
DE3341760C2 (sv) 1989-09-07
IT8349367A0 (it) 1983-11-21
GB2132481A (en) 1984-07-11
SE460825B (sv) 1989-11-27
CH657050A5 (de) 1986-08-15
DE3341760A1 (de) 1984-06-14
CA1204054A (en) 1986-05-06
US4534966A (en) 1985-08-13
JPS5995221A (ja) 1984-06-01
JPH0261925B2 (sv) 1990-12-21
AU552756B2 (en) 1986-06-19

Similar Documents

Publication Publication Date Title
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
NL7900871A (nl) Werkwijze voor de therapeutische behandeling van hyperlipidemie en hyperlipiproteinemie.
ATE384703T1 (de) Piperazinyl-substituierte phenylpyrimidinderivative zur behandlung oder vorbeugung von zns erkrankungen
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DK254887D0 (da) Salve til behandling af hudsygdomme
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO833279L (no) Farmasoeytiske preparater for behandling av uoensket sammenvoksing
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
DE3381624D1 (de) Mittel zur behandlung von wunden.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
SE8306384D0 (sv) Farmaceutisk komposition
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
IT7822027A0 (it) Apparecchio medicale per la cura della trombosi venale profonda.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
NO880292D0 (no) Fremgangsmaate for behandling av humle.
DE3373978D1 (en) Composition for the care or treatment of the human skin
DE3786173D1 (de) Menschlicher monoklonaler antikoerper und arzneimittel zur prophylaxe und behandlung von infektioesen krankheiten.
NO158579C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt n-(2-metoksyetyl)-noroksymorfon.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8306384-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8306384-2

Format of ref document f/p: F